Anaïs Paris

Gain-of-function CRISPR screens identify tumor-promoting genes conferring melanoma cell plasticity and therapy-resistance

D. Gilot, M. Aubry, J. Marine, 2020, bioRxiv.

The AhR‐SRC axis as a therapeutic vulnerability in BRAFi‐resistant melanoma

S. Corre, M. Galibert, E. Leucci, 2022, EMBO molecular medicine.

Role of Flavonoids in the Prevention of AhR-Dependent Resistance During Treatment with BRAF Inhibitors

S. Corre, M. Galibert, Héloïse M Leclair, 2020, International journal of molecular sciences.

CRISPR screens identify tumor‐promoting genes conferring melanoma cell plasticity and resistance

D. Gilot, M. Aubry, J. Marine, 2021, EMBO molecular medicine.

AhR and Cancer: From Gene Profiling to Targeted Therapy

S. Corre, M. Galibert, Anaïs Paris, 2020, International journal of molecular sciences.